Temporal trends and outcomes of acute ischaemic strokes in patients hospitalised for percutaneous coronary intervention
In an unselected nationwide cohort of patients hospitalised for PCI, a gradual increase in AIS incidence was noted. We identified several variables associated with AIS as well as with in-hospital mortality. Hereby, clinicians might identify the patient population at risk for a peri-interventional AIS as well as those at risk for an adverse in-hospital outcome after PCI.
Authors
- Götz Thomalla (ORCID: https://orcid.org/0000-0002-4785-1449)
- Marko Remmel (ORCID: https://orcid.org/0000-0002-8447-5294)
- Stefan Blankenberg (ORCID: https://orcid.org/0000-0001-6488-2362)
- Christoph Waldeyer
- Alina Goßling (ORCID: https://orcid.org/0000-0002-5211-5593)
- Peter Clemmensen
- Benedikt Schrage (ORCID: https://orcid.org/0000-0001-9041-3922)
- David Leander Rimmele (ORCID: https://orcid.org/0000-0003-1625-5721)
- Benjamin Bay (ORCID: https://orcid.org/0000-0002-4927-8033)
- Fabian J. Brunner (ORCID: https://orcid.org/0000-0003-0335-8625)
- Peter Moritz Becher (ORCID: https://orcid.org/0000-0003-1221-7015)
Institutions
- Universität Hamburg (DE)
- University Medical Center Hamburg-Eppendorf (DE)
- German Centre for Cardiovascular Research (DE)
Publication Details
- Journal
- EuroIntervention
- Published
- 2024-08-26
- DOI
- https://doi.org/10.4244/eij-d-24-00189
- Citations
- 1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 0.39
Funders
- Amgen
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- AstraZeneca
- Sanofi
- Alexion Pharmaceuticals
- Stryker
- Amarin Corporation
- Medicines Company
- Abiomed
- Deutsche Forschungsgemeinschaft
- Else Kröner-Fresenius-Stiftung
- Deutsche Herzstiftung
- Servier
- Abbott Diagnostics
- Daiichi Sankyo Europe